DCI:NYSEDonaldson Company, Inc. Analysis
Data as of 2026-03-28 - not real-time
$83.87
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Donaldson’s share price is trading below its short‑term moving average while hovering just above its long‑term trend line, and the RSI is edging toward oversold territory, suggesting a potential technical rebound. The MACD histogram has turned positive, indicating early bullish momentum, and the stock is holding near a key support level in the low‑80s range. Recent earnings missed consensus expectations and operating margins contracted, reflecting pressure on profitability despite a modest revenue increase. The dividend remains modest with a payout ratio well within sustainable limits, providing a defensive cushion. Valuation metrics show a price‑to‑earnings ratio slightly under the industry average, yet a discounted cash‑flow model places intrinsic value far below the current market price, flagging a possible overvaluation. Analyst consensus leans toward a neutral stance with a target price that still offers upside from current levels. Overall, the blend of technical support, dividend safety, and a modest valuation discount creates a nuanced picture: short‑term price support is strong, medium‑term upside exists, but long‑term valuation concerns temper enthusiasm.
The industrial filtration sector remains cyclical and subject to environmental regulation, adding moderate sector and regulatory risk. Global exposure diversifies geographic risk, while the company’s USD‑centric cash flows keep currency risk low. Trading volume has been stable, indicating low liquidity risk. Investors should weigh the near‑term technical upside against the longer‑term valuation gap and margin pressures when forming a position.
The industrial filtration sector remains cyclical and subject to environmental regulation, adding moderate sector and regulatory risk. Global exposure diversifies geographic risk, while the company’s USD‑centric cash flows keep currency risk low. Trading volume has been stable, indicating low liquidity risk. Investors should weigh the near‑term technical upside against the longer‑term valuation gap and margin pressures when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical support near recent lows
- RSI indicating oversold conditions
- Recent earnings miss creating short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential upside to analyst consensus target
- Sustainable dividend with reasonable payout
- Valuation spread relative to peers
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF model suggests price may be stretched
- Steady cash generation supporting dividend
- Cyclical industry exposure and regulatory landscape
Key Metrics & Analysis
Financial Health
Revenue Growth3.00%
Profit Margin10.09%
P/E Ratio26.2
ROE24.27%
ROA11.80%
Debt/Equity43.22
P/B Ratio6.2
Op. Cash Flow$413.9M
Free Cash Flow$253.0M
Industry P/E28.1
Technical Analysis
TrendNeutral
RSI30.0
Support$82.01
Resistance$96.36
MA 20$87.58
MA 50$97.60
MA 200$85.03
MACDBullish
VolumeStable
Fear & Greed Index65.98
Valuation
Fair Value$28.85
Target Price$98.20
Upside/Downside17.09%
GradeOvervalued
TypeValue
Dividend Yield1.43%
Risk Assessment
Beta0.89
Volatility41.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.